Добавил:
kiopkiopkiop18@yandex.ru Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
5 курс / Пульмонология и фтизиатрия / Interventions_in_Pulmonary_Medicine_Díaz_Jimenez.pdf
Скачиваний:
1
Добавлен:
24.03.2024
Размер:
58.79 Mб
Скачать
S. Bilaceroglu (*)
Izmir Faculty of Medicine, Dr. Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, University of Health Sciences, Izmir, Turkey e-mail: semra.bilaceroglu@sbu.edu.tr
lar testing besides having low complication rates. Within the multidisciplinary team approach to identify the best evidence-­based treatment plan for lung cancer care, these minimally invasive procedures have provided rapid and safe acquisition of tissue used for the diagnosis, staging, and molecular testing. The continuous evolution in diagnosis, staging and treatment has led to improved survival and quality of life in lung cancer. Education, training and technological advancements will narrow the gap in the pertinent clinical practice that still exists between academic and community hospitals [14].
Diagnosis and staging of lung cancer should be managed promptly and accurately by an ef cient process minimizing procedures before treatment. The possibility of the ideal tissue acquisition for simultaneous diagnosis, tumor classi cation, molecular testing and staging by the initial procedure depends on the individual patient and the need for suf cient and appropriate tissue for current and future cytological, immunohistochemical, and molecular studies [24].
History and Historical Perspective

Tissue Acquisition in Patients

18

with Suspected Lung Cancer:

Techniques Available and Sampling Adequacy for Molecular Testing

Semra Bilaceroglu

Introduction

Conventional bronchoscopic methods used in the diagnosis and/or staging of lung cancer are endobronchial biopsy, transbronchial biopsy (TBB), brushing, bronchoalveolar lavage (BAL) and bronchial washing. Besides these conventional bronchoscopic methods mediastinoscopy, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), endoscopic ultrasound-guided ne needle aspiration (EUS-­FNA), conventional TBNA, radial-probe EBUS (r-EBUS)-guided procedures, navigational bronchoscopy-­guided procedures, imaging-­guided ne needle aspiration (FNA) or core needle biopsy (CNB), pleural procedures such as thoracentesis, pleural biopsy and medical thoracoscopy, and sputum cytology have also been used for diagnosing and/or staging lung cancer. Of the above-mentioned modalities mediastinoscopy, EBUS-TBNA, EUS-FNA, conventional TBNA, r-EBUS-guided procedures, navigational bronchos- copy-guided procedures, imaging-­guided FNA or CNB, and medical thoracoscopy have been increasingly used minimally invasive tissue sampling modalities in the clinical practice for the last two decades. Furthermore, they can obtain adequate cel-

lular material for pathologic diagnosis and molecuThe most frequently encountered histologic subtypes of lung cancer -the leading cause of cancer deaths worldwide- are adenocarcinoma and ­squamous cell carcinoma as the main epithelial-­ derived non-small cell lung cancer (NSCLC), and small cell lung cancer (SCLC) as the major

© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023

307

J. P. Díaz-Jiménez, A. N. Rodríguez (eds.), Interventions in Pulmonary Medicine, https://doi.org/10.1007/978-3-031-22610-6_18

Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/